The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug Administration.

Under the agreement, the government also could acquire additional doses to vaccinate up to 300 million people, the agencies said.

Related News Articles

Headline
Pfizer today said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow…
Headline
The Federal Emergency Management Agency this week released recommendations to help organizations receiving FEMA COVID-19 public assistance document and…
Headline
The Food and Drug Administration today urged health care facilities to transition away from using crisis capacity conservation strategies, such as…
Perspective
When Congress returns to Washington, D.C., on Monday, lawmakers’ attention will turn to one of the largest infrastructure spending packages in our nation’s…
Headline
The COVID-19 pandemic has shown how crucial technology is for health care delivery, but individuals without broadband access cannot access digital health…
Headline
Nearly 80% of prekindergarten through 12th grade teachers, school staff and child care workers had received at least their first COVID-19 shot by April, the…